Drugs with this side effect
- 2-hydroxysuccinaldehyde: 4% - 26%
- 5-ASA: very rare, postmarketing, 0% - 5%
- 5-aza-2'-deoxycytidine: 27.3% - 39.8%
- 5-azacytidine: 15.2% - 29.5%
- Anidulafungin: 5.6% - 6.87%
- Azarga: uncommon
- Benicar-HCT
- CAS 76095-16-4: 1.3% - 2.2%
- CAS 76420-72-9
- CGP 19835A: very common, 18%
- Cancidas: 6% - 11%
- Carfilzomib: 0% - 26%
- Colimycin M: 55% - 59.4%
- Enfuvirtide: 2.5% - 4.7%
- FAMP: 10% - 44%
- FK463
- FTY720: very common, 10%
- Fe(III: 0% - 6%
- Gd-DTPA
- Gd-EOB-DTPA
- Glat copolymer
- Goserelin: 1-10%
- ICI 182,780: 5.26% - 5.35%
- Implanon
- Insulin: 4.9% - 29.4%
- K779: 0% - 31%
- Kaluril
- LY146032: postmarketing, 3.3% - 6.03%
- Lantus: 7.4% - 12.1%
- Leuprorelin
- Lisinopril: postmarketing, common, 0.5% - 6.4%
- Lutalyse
- Metrodin: 1.7% - 2.6%
- N-acetylcysteine
- NuvaRing
- Octreotide
- Optison: rare
- PCI-32765
- PGE1: 1% - 21%
- PGE2
- Photofrin: 5.81% - 15.1%
- Promacta
- Refludan
- Romidepsin: 0% - 21.3%
- SU5416
- Stalevo 50
- Symlin
- Triptorelin: 1.7%
- UDCA: postmarketing, 7.1%
- VACV: 46% - 57%
- abacavir: 6.17% - 23.5%
- abacavir-lamivudine
- abiraterone: 0% - 0.2%
- acebutolol: 0% - 2%
- acetaminophen: 2%
- acitretin: postmarketing
- aclidinium bromide: 2.99%
- adefovir dipivoxil
- adenosine
- afatinib: 0% - 15%
- alfentanil
- aliskiren: uncommon, 2.83% - 9.48%
- alosetron: rare
- ambrisentan: 5.38% - 7.46%
- amiloride
- amiodarone: postmarketing
- amlodipine
- amlodipine besylate
- amphotericin B
- anagrelide: 6% - 6.3%
- anastrozole: 8-11%
- anthracycline: 0% - 26%
- apremilast
- aprepitant
- argatroban: 1.6% - 2.8%
- aripiprazole: 2% - 3%
- arsenic
- arsenic trioxide
- articaine
- atazanavir: 21%
- atenolol
- atomoxetine: 11%
- atovaquone: 1% - 14%
- avanafil
- axitinib: 1% - 17%
- azelastine
- azilsartan
- aztreonam: 54.1%
- balsalazide: 0% - 5.71%
- beclomethasone
- beclomethasone dipropionate
- beclomethasone monopropionate
- belinostat: 0% - 19%
- benazepril: 0.5% - 1.2%
- benazeprilat: 0.5% - 1.2%
- bendamustine: 0.654% - 4.9%
- benzydamine
- bepridil
- betaxolol: postmarketing
- bexarotene: 10%
- bisoprolol: 2.5% - 4.2%
- boceprevir: very common, 15%
- bortezomib: 0% - 21.1%
- bosentan: 5%
- bosutinib: 0%
- brimonidine
- brinzolamide: postmarketing, rare
- bromfenac
- budesonide: postmarketing, 2% - 9%
- bupivacaine: 0.662% - 1.18%
- buprenorphine: 2.21% - 6.11%
- bupropion: 4%
- busulfan: 28%
- butorphanol: infrequent
- cabazitaxel: 0%
- candesartan: postmarketing
- candesartan cilexetil: postmarketing, 1% - 1.9%
- capecitabine: 0.1% - 22%
- capsaicin: uncommon
- captopril: 15%
- carbidopa
- carboprost
- carnitine: 9% - 18%
- carvedilol
- cefpodoxime
- cefuroxime
- cefuroxime axetil
- celecoxib: 7% - 8%
- cerivastatin
- cetirizine: 2.8% - 4.4%
- cetrorelix
- cevimeline: 6.1%
- chlorhexidine
- chlorpromazine
- ciclesonide
- cilazapril: 1.8% - 7.5%
- cinacalcet: 6%
- citalopram: infrequent, frequent, 1.7%
- cladribine: very common, 7% - 10%
- clarithromycin
- clindamycin phosphate
- clobazam: 3% - 7%
- clofarabine: common
- clomipramine: 4% - 6%
- clonazepam: 2%
- clonidine
- clopidogrel
- clozapine
- copolymer 1
- cyclophosphamide: postmarketing
- cytarabine: 6.61% - 21.4%
- dabigatran etexilate
- dabrafenib: very common, 0% - 29%
- dapsone: 2%
- darifenacin
- darunavir
- dasatinib: 0% - 1%
- deferasirox
- delamanid
- delavirdine
- delta 9-THC: postmarketing
- desloratadine
- desmopressin
- desonide: 1.55% - 3.62%
- dexrazoxane
- diazepam
- diclofenac: 4%
- diethylenetriaminepentaacetic acid
- diltiazem: 1.27% - 2.97%
- dimercaptosuccinic acid
- dipyridamole: 0.03%
- docetaxel: 0% - 9%
- dolasetron
- donepezil
- dorzolamide
- doxapram
- doxazosin
- doxepin: rare
- doxorubicin: 0% - 12%
- doxycycline: 2.4% - 6.1%
- doxycycline hyclate: 4.23%
- duloxetine: 2% - 6%
- efavirenz: 16% - 25%
- eliglustat: 3.77% - 6.6%
- eltrombopag: 23%
- eplerenone: common, 2%
- eprosartan: 4%
- eribulin: 0% - 14%
- erlotinib: 0% - 48%
- ertapenem: 0% - 4.4%
- eslicarbazepine: 2%
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: postmarketing
- etoposide
- etoposide phosphate
- etoricoxib
- everolimus: common, very common, 0% - 25%
- exemestane: 6% - 7%
- exenatide: 1.2% - 3.59%
- ezetimibe
- famotidine
- febuxostat
- felbamate: 6.5%
- felodipine
- fenofibrate
- fenofibric acid
- fentanyl: 3.23% - 8.62%
- ferumoxytol: postmarketing, 1.3% - 1.4%
- fesoterodine: 0.9% - 1.6%
- fexofenadine: 1.9% - 4%
- flecainide
- fludarabine: 0% - 44%
- flumazenil
- fluocinolone acetonide
- fluorescein: very rare, postmarketing, uncommon
- fluphenazine decanoate
- fluticasone: postmarketing, 0% - 6%
- fluticasone furoate: 3.25% - 4.79%
- fluticasone propionate: postmarketing, 3.6% - 9.8%
- fluvastatin: 1.9% - 2.9%
- fluvoxamine
- fondaparinux: rare, 0.636% - 2.09%
- formoterol: postmarketing
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril
- fosinoprilat
- fospropofol
- gabapentin: 1.3% - 2%
- gadobenate dimeglumine: postmarketing
- gadofosveset
- gadolinium: postmarketing
- gadopentetate
- gadoteridol: 0.08%
- gadoversetamide
- galantamine
- ganciclovir: 15.1% - 16%
- gefitinib
- gemcitabine
- gemfibrozil
- gliclazide: 2% - 2.1%
- glycerol
- granisetron: 2.2%
- halofantrine: 3%
- hepatitis B vaccines
- hetastarch: postmarketing
- histamine
- hydrochlorothiazide: 2.6%
- hydrocodone
- hydromorphone
- ibuprofen: 0.658% - 2.99%
- icodextrin: 4% - 7%
- ifosfamide: postmarketing
- iloprost
- imatinib: common, 0% - 27%
- imiquimod: 1% - 2%
- indacaterol: common, 6.46% - 8.2%
- indapamide: 2%
- indinavir: 0.6% - 1.5%
- insulin detemir: 1.8% - 8.2%
- iodide
- iodixanol
- iohexol
- iopromide
- ioversol
- ioxaglate
- ipratropium bromide: postmarketing, common, 0% - 8%
- irbesartan: uncommon, 0.9% - 2.6%
- irbesartan-hydrochlorothiazide: 2.3% - 2.6%
- irinotecan: 0% - 20.2%
- iron sucrose
- isoflurane
- isomannide
- isosorbide-5-mononitrate
- isradipine
- itraconazole: 0% - 10%
- ivermectin: 8% - 11%
- ixabepilone: 0% - 2%
- ketorolac
- ketorolac tromethamine
- lamivudine: 9.72% - 18%
- lamotrigine: 5%
- lansoprazole
- lapatinib: very common, 0% - 9%
- lasofoxifene: uncommon
- leflunomide
- lenalidomide: postmarketing, common, very common, 0.746% - 28.4%
- lercanidipine: very common
- letrozole: uncommon, 5% - 13%
- leuprorelin acetate
- levetiracetam: 9% - 11%
- levocabastine
- levodopa/carbidopa
- levonorgestrel
- linagliptin: uncommon, 2.1%
- linezolid: 0% - 4%
- lisuride
- lomefloxacin
- loratadine
- lorcaserin: 4.26% - 8.2%
- losartan: 3.1% - 69%
- loxapine
- lubiprostone
- mannitol: postmarketing, 1.63% - 7.9%
- maraviroc: 5% - 14%
- megestrol
- meloxicam: 0.2% - 2.4%
- melphalan
- memantine: 3.14% - 4%
- mesna: 4.2% - 10%
- metaproterenol: 0.2% - 1%
- methacholine
- methotrexate
- methylphenidate: common, 1.2% - 1.9%
- metipranolol
- metolazone
- miconazole: 1.7% - 2.8%
- midazolam: 1.3% - 1.9%
- minocycline
- mitoxantrone: 2% - 13%
- modafinil
- moexiprilat: 0.7%
- mometasone: postmarketing, 7%
- mometasone furoate
- montelukast: 2.7%
- morphine
- mupirocin: 2%
- mycophenolate mofetil
- mycophenolic acid: 8% - 11.3%
- nabilone
- nabumetone: postmarketing, 0.6%
- nadolol
- naltrexone
- naratriptan: infrequent
- nateglinide: 2.2% - 2.4%
- nedocromil sodium
- nelarabine: 0% - 25%
- niacin: 2% - 8%
- nicotine
- nifedipine: 6%
- nilotinib: common
- nitrofurantoin
- nizatidine: postmarketing, 2%
- ofatumumab: 0% - 19%
- ofloxacin
- olanzapine: 3% - 9%
- olmesartan: postmarketing, common, 0.225% - 4.3%
- olmesartan medoxomil
- olodaterol: 4.22%
- olopatadine: 0.506% - 1.36%
- omeprazole: 1.07% - 1.5%
- ondansetron
- orlistat
- oseltamivir: postmarketing
- oxaliplatin: very common, 0% - 13%
- oxcarbazepine: 0% - 5%
- oxybutynin: 1.9% - 3%
- oxycodone
- paclitaxel: very rare, postmarketing, rare, 6% - 7%
- paliperidone: 1% - 3%
- pamidronate: 21.2% - 26.3%
- pantoprazole
- paricalcitol: 2.8% - 3%
- paroxetine
- pazopanib: 0% - 17%
- pemirolast
- penbutolol: 1.1% - 2.1%
- pentamidine: 62.7%
- pentostatin: 15% - 20%
- perampanel: 1% - 4%
- perindopril: 6% - 12%
- perindopril erbumine: 13%
- perindoprilat
- perphenazine
- phencyclidine
- pimecrolimus: 2.4% - 15.8%
- pirbuterol: 0% - 1.2%
- pirfenidone
- pixantrone
- pomalidomide: 14% - 20.5%
- ponatinib: 0% - 18%
- posaconazole: 3.23% - 25.1%
- pralatrexate
- pramipexole: 1.6% - 3%
- prasugrel: 3.9% - 4.1%
- pravastatin: 0.1% - 8.2%
- pregabalin
- procarbazine
- prochlorperazine
- progesterone: 0% - 8%
- proguanil
- propafenone
- propofol
- propranolol
- prostacyclin
- quetiapine: 2% - 3%
- quinapril: 0.128%
- quinaprilat: 0.128%
- rabeprazole
- raltegravir
- raltitrexed: 2%
- ramipril: 1% - 7%
- ramiprilat: 1% - 7%
- ranolazine
- rasagiline: 4%
- rasburicase
- regadenoson: common
- remifentanil: 0% - 1.32%
- retinoic acid
- ribavirin: common, very common, 7% - 17%
- rifapentine
- rifaximin: 7.14%
- rimantadine
- risedronate: 1.2% - 2.6%
- risperidone: 0% - 24%
- ritonavir
- rivastigmine: infrequent, frequent
- rizatriptan: rare
- rofecoxib
- ropinirole: 3%
- ropivacaine: 1.3%
- rotigotine: 3%
- salbutamol: postmarketing, 1% - 5%
- salmeterol: 5%
- salmon calcitonin acetate: postmarketing
- saquinavir
- sertraline: infrequent
- sevelamer hydrochloride: 7.1% - 12.9%
- sevoflurane
- sibutramine
- sildenafil: 5% - 9%
- sitagliptin
- sodium cromoglycate
- sodium ferric gluconate: 6%
- sodium iothalamate
- sofosbuvir: common, very common
- solifenacin: 0.2% - 1.1%
- sorafenib
- sotalol: 2.5% - 3.3%
- sugammadex
- sulfamethoxazole
- sulfasalazine
- sumatriptan: rare
- sunitinib
- suvorexant: 2%
- tacrolimus: common
- tadalafil: 2% - 9%
- tafluprost: 3%
- tamoxifen: 1% - 4-10%
- tamsulosin
- tapentadol
- teduglutide
- telmisartan: very rare, postmarketing, uncommon, common, 1.4% - 1.6%
- temozolomide: common, 0% - 8.48%
- temsirolimus
- terbinafine: 5% - 6%
- testosterone: postmarketing
- testosterone undecanoate
- tetrahydrobiopterin: 6.76%
- tetrofosmin
- thalidomide: 0% - 18.6%
- thiotepa
- thiothixene
- thymidine: 0.4% - 7%
- ticagrelor: 4.6% - 4.9%
- timolol
- tiotropium
- tipranavir: 5.5%
- tobramycin: very common, 31.1% - 48.4%
- tofacitinib
- topiramate: 0% - 7%
- topotecan: 0% - 15%
- torasemide: 2%
- trabectedin
- tramadol: postmarketing, uncommon
- trametinib: 0% - 29%
- trandolapril: 2.6% - 35%
- trandolaprilat: 35%
- travoprost: rare, uncommon
- treprostinil: 53.9%
- triamcinolone: 9.4%
- triamcinolone acetonide
- trifluoperazine
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trovafloxacin
- umeclidinium: 3%
- v 1784: postmarketing, 3% - 5%
- valdecoxib
- valganciclovir: 1.92% - 16%
- valsartan: uncommon, 0.6% - 2.7%
- vandetanib: 10.8%
- varenicline: infrequent, uncommon
- vemurafenib: postmarketing, 0% - 12%
- vernakalant: common
- verteporfin
- vigabatrin: 2% - 14%
- vinflunine
- vinorelbine
- voriconazole
- vorinostat
- zalcitabine
- zanamivir: 1% - 17%
- zidovudine: rare, 15% - 18%
- zidovudine/lamivudine
- zoledronic acid: uncommon, 10% - 12%
- zolpidem: infrequent
|
Drugs with this indication
|
